{"id":103077,"date":"2020-03-01T04:02:59","date_gmt":"2020-03-01T12:02:59","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/03\/two-new-breakthrough-melanoma-treatments-added-to-pbs"},"modified":"2020-03-01T04:02:59","modified_gmt":"2020-03-01T12:02:59","slug":"two-new-breakthrough-melanoma-treatments-added-to-pbs","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/03\/two-new-breakthrough-melanoma-treatments-added-to-pbs","title":{"rendered":"Two new \u2018breakthrough\u2019 melanoma treatments added to PBS"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/two-new-breakthrough-melanoma-treatments-added-to-pbs.jpg\"><\/a><\/p>\n<p>More than 2000 Australian suffering from advanced melanoma will soon receive financial relief with an expansion of treatments on the Pharmaceutical Benefits Scheme, federal Health Minister Greg Hunt says.<\/p>\n<p>From March 1 the PBS listed Opdivo (nivolumab) will be expanded, assisting 1500 patients who might otherwise pay more than $100,000 per course of treatment without the PBS subsidy.<\/p>\n<p>\u201cOpdivo is a breakthrough immunotherapy which works by blocking proteins and helping the body\u2019s own immune system to find, attack and destroy cancer cells,\u201d Mr Hunt said in a statement on Sunday.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>More than 2000 Australian suffering from advanced melanoma will soon receive financial relief with an expansion of treatments on the Pharmaceutical Benefits Scheme, federal Health Minister Greg Hunt says. From March 1 the PBS listed Opdivo (nivolumab) will be expanded, assisting 1500 patients who might otherwise pay more than $100,000 per course of treatment without [\u2026]<\/p>\n","protected":false},"author":396,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,45,1495],"tags":[],"class_list":["post-103077","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-finance","category-health"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/103077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/396"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=103077"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/103077\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=103077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=103077"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=103077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}